巩膜胶原交联疗法治疗进行性近视的研究进展  

Advanced research in Sclera collagen cross-linking treating progressive myopia

作　　者：赵燕燕[1] 赵红红[1] 张丰菊[1] 

机构地区：[1]首都医科大学附属北京同仁医院北京同仁眼科中心北京市眼科学与视觉科学重点实验室,100730

出　　处：《中华眼科杂志》2010年第11期1048-1051,共4页Chinese Journal of Ophthalmology

基　　金：国家自然科学基金（81070763）

摘　　要：胶原交联是指胶原分子内部和胶原分子间通过共价键结合实现提高胶原纤维的张力和稳定性的目的 .胶原交联被广泛应用于其他行业,近期研究表明胶原交联可改变巩膜的生物力学性质,使其抗牵拉能力增强,从而阻止进行性近视的发展恶化,有望成为治疗进行性近视的新疗法,本文对进行性近视巩膜胶原的特点、传统治疗方法及巩膜胶原交联疗法的研究现状做一阐述.Collagen can link between or within collagen molecules through the covalent bond, which leads to increasing the tension and stability of collagen fiber. Collagen cross-linking had been widely used in other industries, the recent research showed that cross-linking of scleral collagen increased the scleral biomechanical rigidity efficiently, which might become a new treatment modality for strengthening scleral tissue to prevent progressive myopia. This review describes the sclera collagen characteristics of progressive myopia, traditional treatment and sclera collagen cross-linking therapy.

关 键 词：巩膜 胶原 近视 退行性 

分 类 号：R686[医药卫生—骨科学]